Omeprazole

Phase 1Completed

0 watching 0 views this week💤 Quiet

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Bioequivalence, AUC, Cmax, Pharmacokinetics

Conditions

Bioequivalence, AUC, Cmax, Pharmacokinetics

Trial Timeline

Aug 1, 2013 → Nov 1, 2013

NCT ID

NCT01921920

About Omeprazole

Omeprazole is a phase 1 stage product being developed by AstraZeneca for Bioequivalence, AUC, Cmax, Pharmacokinetics. The current trial status is completed. This product is registered under clinical trial identifier NCT01921920. Target conditions include Bioequivalence, AUC, Cmax, Pharmacokinetics.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (5)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01921920	Phase 1	Completed	Aug 1, 2013	Nov 1, 2013	Bioequivalence, AUC, Cmax, Pharmacokinetics
NCT00259051	Phase 3	Completed	Jan 1, 2004	Aug 1, 2004	Non-erosive Reflux Disease
NCT00259077	Phase 3	Completed	Oct 1, 2003	Jul 1, 2004	Non-erosive Reflux Disease
NCT00641264	Approved	Completed	May 1, 2001	Jun 1, 2003	Laryngopharyngeal Reflux (LPR)
NCT00256737	Phase 3	Completed	Jan 1, 1998	Oct 1, 2005	GERD

Competing Products

20 competing products in Bioequivalence, AUC, Cmax, Pharmacokinetics

See all competitors

Product	Company	Stage	Hype Score
Bupropion HCl MR tablets 300mg	Alembic Pharmaceuticals	Phase 1	32
Fingolimod 0.5 mg capsules- Test drug	Alembic Pharmaceuticals	Phase 1	32
Lamotrigine ER tablet 50mg	Alembic Pharmaceuticals	Phase 1	32
Sonelokimab + Sonelokimab	MoonLake Immunotherapeutics	Phase 1	28
GP30101 + Prezista® + GP30101 + Prezista®	GEROPHARM	Pre-clinical	15
Metformin + Glucophage® + Metformin + Glucophage®	GEROPHARM	Phase 1	25
Metformine + Glucophage® Long + Metformin + Glucophage® Long	GEROPHARM	Phase 1	25
Humulin® Regular + Rinsulin® R	GEROPHARM	Pre-clinical	15
Bosentan 125 mg + Tracleer 125Mg Tablet	GEROPHARM	Phase 1	25
Rinsulin® mix 30/70 + Humulin® M3	GEROPHARM	Pre-clinical	15
Memantinol tablets, 20 mg + Akatinol Memantine® tablets, 20 mg	GEROPHARM	Phase 1	25
Clocortolone Pivalate	Sun Pharmaceutical	Phase 1	33
Oxymetazoline hydrochloride Cream, 1% + Rhofade™ (oxymetazoline) cream, 1% + Placebo	Sun Pharmaceutical	Phase 1	33
Tablet paracetamol, guaifenesin and phenylephrine HCL + Vicks Active SymptoMax Plus powder for oral solution	Johnson & Johnson	Phase 1	33
SHR-1314	Jiangsu Hengrui Medicine	Phase 1	33
Onglyza (saxagliptin) + Diabex + 5-mg saxagliptin/1000 mg metformin + Diabex + 5-mg saxagliptin/500 mg metformin	AstraZeneca	Phase 1	33
selumetinib 75mg single dose + selumetinib 75mg single dose + selumetinib 75mg single dose	AstraZeneca	Phase 1	33
dapagliflozin/metformin XR 5/500 mg test drug (Mount Vernon) + dapagliflozin/metformin XR 5/500 mg reference drug (Humacao) + dapagliflozin/metformin XR 10/1000 mg test drug (Mount Vernon) + dapagliflozin/metformin XR 10/1000 mg reference drug (Humacao)	AstraZeneca	Phase 1	33
D961S + Esomeprazole + Buffered acetylsalicylic acid	AstraZeneca	Phase 1	33
Treatment A: Acalabrutinib tablet + Treatment B: Acalabrutinib capsule	AstraZeneca	Phase 1	33

Other Products from AstraZeneca

QuetiapineApproved

Dapagliflozin 5 mg + Placebo tabletApproved

QuetiapineApproved

Ticagrelor + ClopidogrelApproved

DurvalumabApproved